Shares of health insurance companies are trading higher the U.S. CMS awarded five- and four-star ratings to plans offered by UnitedHealth Group, Clover, and Humana among others. Also, Humana reaffirmed its FY26 adjusted EPS guidance and issued optimistic comments about FY27 and FY28.

Growth Lead Sectors In Friday Trading As Defensives Trail

Seven sectors are higher and four are lower in Friday’s regular session, with growth sectors holding the top three positions. The leaders are separated rather than clustered, with no single gap clearly standing apart from the other breaks across the table.

UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5.5

UBS Adjusts Price Target on Clover Health Investments to $5.50

UBS has raised its price target for Clover Health Investments, Corp. from $5.00 to $5.50 while maintaining a Neutral rating.

Sunflower State Health Plan Earns 4-Star NCQA Rating

Sunflower State Health Plan, a subsidiary of Centene Corporation, received a 4 out of 5-star rating in the 2026 NCQA Medicaid Health Plan Ratings.

US Department of Justice Intervenes in Whistleblower Lawsuit Against Centene Corporation

The U.S. government has intervened in a False Claims Act lawsuit alleging that Centene Corporation engaged in fraudulent Medicare Advantage enrollment practices.

History Says This ETF Is a Fantastic Buy-and-Hold Investment -- and It Could Turn $100 per Month Into $359,492

The Schwab U.S. Dividend Equity ETF (SCHD) is highlighted as a strong buy-and-hold investment with a 15-year annualized return of 13.11%. The article suggests that $100 monthly investments could grow to $359,492 over 30 years. SCHD offers diversification away from AI stocks with holdings in energy, healthcare, and consumer staples sectors, making it potentially attractive for investors concerned about tech stock volatility.